Title : Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice.

Pub. Date : 2002 Jan

PMID : 11843949






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Data from the Heart Outcomes Prevention Evaluation (HOPE) trial demonstrated that CV risk can be further reduced by the addition of the ACE inhibitor ramipril to the existing treatment regimen of high-risk patients with diabetes. Ramipril angiotensin I converting enzyme Homo sapiens